Diabetes is the strongest risk factor of hepatic fibrosis in lean patients with non-alcoholic fatty liver disease

Affiliations

¹ Department of Family Medicine, Eulji University Hospital in Uijeongbu, Uijeongbu-si, Korea (the Republic of).
² Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea (the Republic of).
³ Department of Laboratory Medicine, Health Promotion Research Institute, Seoul, Korea (the Republic of).
⁴ Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea (the Republic of) noshin@hanyang.ac.kr cellonah@hanmail.net.
⁵ Department of Laboratory Medicine, Health Promotion Research Institute, Seoul, Korea (the Republic of) noshin@hanyang.ac.kr cellonah@hanmail.net.

^# Contributed equally.

Comment

Huiyul Park et al. Gut. 2022 May.

. 2022 May;71(5):1035-1036.

doi: 10.1136/gutjnl-2021-325102. Epub 2021 Jun 14.

¹ Department of Family Medicine, Eulji University Hospital in Uijeongbu, Uijeongbu-si, Korea (the Republic of).
² Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea (the Republic of).
³ Department of Laboratory Medicine, Health Promotion Research Institute, Seoul, Korea (the Republic of).
⁴ Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea (the Republic of) noshin@hanyang.ac.kr cellonah@hanmail.net.
⁵ Department of Laboratory Medicine, Health Promotion Research Institute, Seoul, Korea (the Republic of) noshin@hanyang.ac.kr cellonah@hanmail.net.

^# Contributed equally.

No abstract available

Keywords: nonalcoholic steatohepatitis.

Conflict of interest statement

Competing interests: None declared.

NAFLD in lean individuals: not a benign disease.
Francque S, Wong VW. Francque S, et al. Gut. 2022 Feb;71(2):234-236. doi: 10.1136/gutjnl-2021-324162. Epub 2021 Mar 12. Gut. 2022. PMID: 33712438 No abstract available.